Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00189
|
|||||
| Drug Name |
Serotonin
|
|||||
| Synonyms |
1H-Indol-5-ol, 3-(2-aminoethyl)-; 3-(2-Amino-ethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)-1H-indol-5-ol; 3-(2-Aminoethyl)indol-5-ol; 3-(beta-Aminoethyl)-5-hydroxyindole; 333DO1RDJY; 5-HT; 5-HYDROXYTRYPTAMINE; 5-Hta; 5-Hydroxy-3-(beta-aminoethyl)indole; 50-67-9; Antemoqua; Antemovis; BRN 0143524; CHEBI:28790; Ds substance; EINECS 200-058-9; Enteramin; Enteramine; Hippophain; Indol-5-ol, 3-(2-aminoethyl)-; Serotonine; Substance DS; Substanz DS; Thrombocytin; Thrombotonin; Tryptamine, 5-hydroxy-; UNII-333DO1RDJY
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C10H12N2O
|
|||||
| Canonical SMILES |
C1=CC2=C(C=C1O)C(=CN2)CCN
|
|||||
| InChI |
InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2
|
|||||
| InChIKey |
QZAYGJVTTNCVMB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 50-67-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 176.21 | Topological Polar Surface Area | 62 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
0.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
11111288
, 11111289
, 11120330
, 11120818
, 11121306
, 11121741
, 11122221
, 11362866
, 11364882
, 11365428
, 11367444
, 11367990
, 11370006
, 11370943
, 11370944
, 11373045
, 11373591
, 11375606
, 11376152
, 11378175
, 11466509
, 11467629
, 11485998
, 15120541
, 26737386
, 26754231
, 26754232
, 26754233
, 29224259
, 3249485
, 4041
, 47662064
, 47662065
, 47662066
, 47662067
, 47662068
, 47810539
, 47810540
, 47885201
, 47885202
, 47885203
, 47959524
, 48110239
, 48259014
, 48334252
, 6492753
, 7978601
, 803912
, 8144285
, 8153195
|
|||||
| ChEBI ID |
CHEBI:28790
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ENT4 | Transporter Info | Equilibrative nucleoside transporter 4 | Substrate | [1] | |
| OCT-2 | Transporter Info | Organic cation transporter 2 | Substrate | [2] | ||
| SERT | Transporter Info | Sodium-dependent serotonin transporter | Substrate | [3] | ||
| VMAT1 | Transporter Info | Vesicular amine transporter 1 | Substrate | [4] | ||
| VMAT2 | Transporter Info | Vesicular amine transporter 2 | Substrate | [4] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OCT-2 | Transporter Info | Km = 290 microM | Human embryonic kidney cells (HEK293)-OCT2 | [2] | |
| OCT-2 | Transporter Info | Km = 80 microM | Oocytes-OCT2 | [5] | ||
| References | ||||||
| 1 | Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Mol Autism. 2014 Aug 13;5:43. | |||||
| 2 | Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006 Jun;50(8):941-52. | |||||
| 3 | Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet. 2009 Dec;2(6):614-20. | |||||
| 4 | SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med. 2013 Apr-Jun;34(2-3):360-72. | |||||
| 5 | Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 1998 Aug;54(2):342-52. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.